Recommendations For Cancer Prevention.

Recommendations For Cancer Prevention.
Nine of 10 women do not emergency and should not collect genetic testing to see if they are at risk for breast or ovarian cancer, an influential panel of robustness experts announced Monday. The US Preventive Services Task Force (USPSTF) reaffirmed its one-time recommendation from 2005 that only a limited number of women with a family history of knocker cancer be tested for mutations in the BRCA1 and BRCA2 genes that can increase their cancer risk. Even then, these women should review the test with both their family doctor and a genetic counselor before proceeding with the BRCA genetic test, the panel said.

And "Not all men and women who have positive family histories should be tested. It's not at all slow-witted or straightforward," said Dr Virginia Moyer, the task force's chair. Interest mid women in genetic testing for breast cancer has greatly increased, entirely due to Hollywood film star Angelina Jolie's announcement in May that she underwent a double mastectomy because she carried the BRCA1 mutation. A Harris Interactive/HealthDay ask conducted a few months after Jolie's declaration found as many as 6 million women in the United States planned to get medical advice about having a hindrance mastectomy or ovary removal because of the actress' personal decision.

On average, mutations of the BRCA genes can inflation breast cancer risk between 45 percent to 65 percent, according to the American Cancer Society. The emotionally upset is that there are myriad mutations of the BRCA gene. Doctors have identified some mutations that augment breast cancer risk, but there are many more BRCA mutations where the increased risk is either lowly or as yet unknown. "The test is not something that comes back positive or negative.

The test comes back a fit lot of different ways, and that has to be interpreted," Moyer said. "There are a variety of mutations. Often you get what appears to be a cancelling test but we call it an 'uninformative' negative because it just doesn't tell you anything. A old lady would walk away from that with no idea, but worried, and that's not helpful".

Earlier this month, the genetic testing company 23andMe announced it's no longer gift health information with its home-based kit service after the US Food and Drug Administration warned that the check-up is a medical device that requires government approval. The remodelled task force recommendations will be published online Dec 23, 2013 in the Annals of Internal Medicine. The charge force's judgment carries heavy cross within the health care industry.